France 2030 deploys its €54 billion through a sophisticated portfolio of funding mechanisms, each designed for a specific stage of the innovation-to-industrialization pipeline. Navigating this landscape — understanding which competition applies to your project, what it funds, at what rates, with what obligations — is the foundational skill for anyone seeking France 2030 capital. The differences between an i-Nov grant and an i-Démo are not bureaucratic nuances; they represent fundamentally different risk profiles, funding amounts, and strategic purposes.

This guide provides the most comprehensive English-language explanation of France 2030’s competition types — from the smallest pre-seed grants for doctoral teams to the multi-billion-euro sector acceleration programs targeting industrial-scale deployment. It covers not just the formal mechanics of each program but the strategic logic behind the portfolio — why France designed these instruments the way it did, and what that means for applicants trying to position their projects optimally.

The mental model that clarifies everything: France 2030’s competitions map to the Technology Readiness Level (TRL) scale. Programs at the left end of the TRL spectrum (TRL 1–4) fund scientific risk; programs in the middle (TRL 4–7) fund technology and market validation risk; programs at the right end (TRL 7–9) fund industrial and commercial execution risk. The funding amounts, eligibility criteria, co-financing requirements, and evaluation standards all shift systematically across this spectrum.

The TRL Framework: Your Navigation Tool

The Technology Readiness Level scale, originally developed by NASA and adopted by the EU’s Horizon Europe framework, classifies technology maturity from TRL 1 (basic principles observed) to TRL 9 (actual system proven in operational environment). France 2030’s competition portfolio maps cleanly to this framework:

• TRL 1–3: ANR research programs, CIFRE doctoral grants, SATT maturation funding
• TRL 4–6: Concours d’Innovation (Phase 1 and 2), i-Nov
• TRL 6–8: i-Démo, sector-specific AMIs, ADEME hydrogen and decarbonization calls
• TRL 8–9: First Technology, First Factory, sector acceleration programs
• TRL 9+: IPCEI, large-scale industrial financing, Bpifrance equity

Understanding your current TRL — and being realistic about it — is the single most important step in competition selection. Overclaiming TRL in applications (asserting TRL 6 for a TRL 4 project) is a common error that evaluators detect immediately and that severely damages application credibility.

Concours d’Innovation — The Deep-Tech Genesis Program

Operator: Bpifrance Stage: Pre-company to early startup (TRL 2–5) Funding range: €100,000–€600,000 (grant) Co-financing requirement: Minimal at Phase 1; up to 50% at Phase 2 Frequency: 2 competitive waves per year Eligibility: Academic teams (pre-company) at Phase 1; French-registered companies under 8 years at Phase 2

The Concours d’Innovation (CI) — formerly known as i-Lab — is France 2030’s entry-level deep-tech program and the most important instrument for academic researchers considering commercial applications of their research. Its distinctive feature is Phase 1 eligibility for pre-company teams: a research group at a university, grande école, or CNRS laboratory can apply without forming a company, using the grant to develop a proof of concept, conduct market research, and decide whether commercialization is viable before committing to incorporation.

Phase 1 (Pre-creation):

• Recipients: Academic research teams (not yet incorporated)
• Grant: €100,000–€300,000 (100% of eligible costs — no co-financing required)
• Duration: 6–18 months
• Objectives: Demonstrate technical feasibility of the core innovation; develop initial IP position (file patent or begin process); conduct customer discovery to assess commercial viability; evaluate team’s willingness and capacity to create a startup
• Evaluation criteria: Scientific excellence and innovation level; team track record; IP potential; commercial opportunity plausibility

Phase 2 (Creation and growth):

• Recipients: Startups incorporated during or after Phase 1, or directly eligible startups at early TRL
• Grant: €300,000–€600,000 (typically 45–70% of eligible costs)
• Duration: 12–24 months
• Objectives: Demonstrate the technology at prototype level (TRL 5–6); initiate commercial development (first customer agreements); recruit core team; file additional IP; prepare for seed funding
• Evaluation criteria: Technical progress relative to Phase 1 promise; team strengthening; commercial traction; investor readiness

Sector priority tracks: Each CI wave specifies France 2030 priority sectors (announced in the call documentation). In recent waves, priority has included quantum computing, AI, novel materials, biotech/biotherapies, space systems, and energy storage.

Strategic importance: CI is the most important quality signal in the French deep-tech ecosystem. A CI Phase 2 win opens doors at VC firms and makes subsequent Bpifrance applications substantially more competitive. Alumni include early-stage versions of several companies now worth hundreds of millions of euros.

i-Nov — The Scale-Up Innovation Competition

Operator: Bpifrance Stage: Startup to young SME (TRL 4–7) Funding range: €200,000–€2,000,000 (grant or repayable advance) Co-financing requirement: 30–55% of project costs (decreasing for smaller companies) Frequency: 4–6 competitive waves per year Eligibility: French startups and SMEs under 8 years (up to 2,000 employees in some cases)

i-Nov is Bpifrance’s workhorse innovation competition — the program that has funded more France 2030-aligned startups than any other single instrument. Its design reflects a deliberate philosophy: France 2030 needs to support not just breakthrough scientific projects (CI’s domain) but the much larger population of commercially-oriented startups translating proven science into market products.

The distinction from CI is critical: i-Nov does not require fundamental scientific novelty. It requires significant technological innovation — developing a product or process significantly better than existing alternatives, even if the underlying science is established. A startup applying advanced manufacturing techniques to reduce battery cost by 30% would be competitive for i-Nov; it would not be competitive for CI (which requires fundamental scientific novelty).

What i-Nov funds:

• Development of an innovative product, service, or process
• Construction and testing of prototypes and demonstrators
• Feasibility studies and technical optimization
• IP protection (patent application and prosecution costs)
• Technical and economic studies

What i-Nov does NOT fund:

• Routine product development without significant innovation
• Commercial activities (sales, marketing, distribution)
• Working capital
• Acquisitions

The wave structure: i-Nov operates in waves (vagues) of approximately 4–6 months each. Each wave specifies priority sectors aligned with France 2030 — sectors that are not on the current wave’s priority list may still apply under a general technology track, but face lower odds. The key strategic decision: time your application to a wave where your sector is explicitly prioritized.

Scoring criteria (standard across waves):

• Innovation level and competitiveness (vs. international state of the art): 30%
• Commercial and economic viability: 25%
• Team capacity and expertise: 25%
• Strategic alignment with France 2030 objectives: 20%

Grant vs. repayable advance: For commercially stronger projects with clearer revenue paths, Bpifrance may structure all or part of i-Nov support as a repayable advance (conditionally repayable upon commercial success). This is not a disadvantage — it signals that Bpifrance has high confidence in the project’s commercial potential.

i-Démo — Industrial Demonstration at Scale

Operator: Bpifrance Stage: Pre-industrialization demonstration (TRL 6–8) Funding range: €2,000,000–€30,000,000+ (grant and/or repayable advance) Co-financing requirement: 40–75% of project costs Frequency: Annual to biannual competitive calls Eligibility: Companies of any size (SMEs, mid-caps, large groups) — often requires consortium

i-Démo funds large-scale industrial demonstrations of technology that has been validated at laboratory or pilot scale but has not yet been proven at pre-commercial or full industrial scale. The gap between laboratory proof-of-concept (TRL 6) and commercially deployable industrial process (TRL 9) is often the most capital-intensive and technically risky part of the innovation journey — and the stage where private capital is least available. i-Démo is specifically designed to bridge this “valley of death.”

What makes i-Démo different from i-Nov:

• Scale: i-Démo typically funds full-scale demonstration facilities, not lab prototypes
• Consortia: Most i-Démo projects involve multiple partners (technology developer + industrial user + research institution)
• EU alignment: Many i-Démo projects are also eligible for Horizon Europe funding or IPCEI participation — Bpifrance explicitly coordinates with EU funding mechanisms
• Long duration: i-Démo projects typically run 3–5 years (vs. 1–2 years for i-Nov)

Typical i-Démo project types:

• First demonstration of a new electrolyzer technology at 10+ MW scale
• Industrial-scale demonstration of a carbon capture system at a cement plant
• First pilot production line for a novel semiconductor process
• Scale-up of a biotherapy manufacturing process from lab to GMP pilot plant
• Demonstration of an autonomous navigation system for agricultural machinery

Consortium requirements: i-Démo strongly prefers projects with end-user commitment. A technology developer proposing to demonstrate their hydrogen storage innovation in partnership with an industrial offtaker (that has signed a letter of intent to use the technology) will systematically outperform a standalone developer application.

First Factory — From Prototype to Production

Operator: Bpifrance Stage: First industrial deployment (TRL 8–9) Funding range: €5,000,000–€50,000,000+ (repayable advance or grant) Co-financing requirement: 50–80% of project costs Frequency: Sector-specific calls, often annual Eligibility: Companies with demonstrated technology, planning first industrial-scale production facility

First Factory (anciennement “Première Usine”) is France 2030’s support mechanism for the specific challenge of building a company’s first industrial-scale manufacturing facility — the transition from prototype/pilot to commercial production. This stage is capital-intensive (typically €10–100 million for a first factory in France 2030 priority sectors), long in timeline (2–5 years from design to first production), and commercially uncertain (production costs at scale are not yet proven).

Strategic context: France 2030’s reindustrialization agenda explicitly requires that IP developed in French research laboratories results in French manufacturing capacity — not manufacturing capacity in Asia or elsewhere. First Factory directly incentivizes this localization decision by providing significant public co-financing for French industrial facilities.

Key requirements:

• Technology demonstrated at TRL 7–8 (demonstrator or pre-production validation)
• Business plan demonstrating commercial viability at industrial scale
• Site identified in France with planning permission initiated
• Co-financing capacity documented (equity, bank loans, regional grants)
• Job creation plan (typically 30–200 jobs for qualifying projects)

Sectors with dedicated First Factory programs:

• Battery cells and materials (northern France cluster)
• Hydrogen electrolyzers
• Semiconductor advanced packaging
• Bioproduction and cell therapy manufacturing
• Satellite component manufacturing
• Sustainable aviation fuel production

Sector Acceleration Programs — Large-Scale Strategic Investments

Beyond the generalist programs above, France 2030 includes approximately 20–30 sector-specific acceleration programs — large-scale competitive calls targeting specific technology challenges within each of France 2030’s ten strategic sectors. These programs typically offer larger funding amounts (€10–200 million per project) and are designed to attract either large industrial groups or startups with significant demonstrated commercial traction.

IPCEI (Important Projects of Common European Interest): The IPCEI framework is not technically a “competition” in the traditional sense — it is a European state aid exception that allows France (and other member states) to fund projects with direct grants at rates that would otherwise violate EU competition rules. IPCEI projects are coordinated at the European level, with France 2030 funding French participants in pan-European consortia.

Active IPCEIs relevant to France 2030:

• IPCEI Hydrogène: Funds the hydrogen electrolyzer and fuel cell supply chain (Genvia, McPhy, and others)
• IPCEI Batteries (EuBatIn): Funds the battery cell and material supply chain (ACC, Verkor, Saft)
• IPCEI Microelectronics 2: Funds next-generation semiconductor and embedded AI projects (STMicroelectronics, Soitec, Thales)
• IPCEI Cloud (IPCEI CIS): Funds European sovereign cloud infrastructure (OVHcloud, Orange, others)
• IPCEI Santé: Funds biotherapy and health data infrastructure

For large companies and well-funded startups, IPCEI participation — coordinated through SGPI with Bpifrance implementing — provides the largest France 2030 grant amounts (often €50–500 million per project) and explicit protection from EU competition law challenges.

AMI (Appel à Manifestation d’Intérêt) — Calls for Expression of Interest: AMIs precede formal competitions and are used when SGPI or Bpifrance wants to assess market appetite before designing a program. An AMI response is typically a 5–15 page concept note. It is not binding — responding does not commit you to apply to the subsequent formal competition. However, AMI responses shape program design: if 30 companies respond to an AMI with battery cell technology and only 2 respond with battery recycling, the subsequent AAP will likely weight battery cells more heavily.

Strategic rule: Never miss a relevant AMI. The cost (time for a 10-page concept note) is low; the benefit (program design influence + Bpifrance relationship building) is high.

ADEME-Managed Programs: The Energy Transition Portfolio

While Bpifrance manages the majority of France 2030’s innovation competitions, ADEME (the Agence de la Transition Ecologique) manages a significant parallel portfolio covering energy transition, hydrogen, industrial decarbonization, and circular economy programs.

Key ADEME programs relevant to France 2030:

Appels à Projets Hydrogène: Multiple hydrogen-specific competitive calls, including:

• “Ecosystèmes Territoriaux Hydrogène” — geographic clusters combining production, distribution, and use
• “Briques Technologiques Hydrogène” — component and technology development for electrolyzers and fuel cells
• “Grandes Usines Hydrogène” — large-scale production facilities (>100 MW electrolyzer capacity)

Appels à Projets Industrie Décarbonée: Targeting France 2030’s industrial decarbonization objective, with specific tracks for heat process decarbonization, carbon capture, and industrial efficiency.

Fonds Chaleur: Supports renewable heat projects (biomass, geothermal, solar thermal) — technically pre-dates France 2030 but fully integrated into its industrial decarbonization objective.

Appels à Projets Biogaz: Supporting biogas production from agricultural and food waste — connecting France 2030’s food/agriculture objective to the energy transition.

For companies working in energy, hydrogen, or industrial decarbonization, ADEME programs should be evaluated in parallel with Bpifrance programs. ADEME sometimes offers larger absolute grants for energy infrastructure projects, with a stronger emphasis on ecological impact metrics.

ANR Programs: The Research Foundation

The Agence Nationale de la Recherche (ANR) manages France 2030’s fundamental and applied research competitions. For companies at very early stages of technology development, or for researchers considering commercialization, ANR programs are the critical entry point.

AAPG (Appel à Projets Générique): ANR’s general annual competition for fundamental research projects, covering all scientific disciplines. France 2030 has expanded ANR’s budget and added sectoral priority tracks aligning with France 2030 objectives.

LabCom (Laboratoire Commun): Joint laboratory programs between a research institution and an industrial partner — an excellent instrument for companies wanting to maintain a deep research connection while commercializing technology. LabCom funds the establishment of a dedicated shared research team and infrastructure.

PEPR (Programmes et Equipements Prioritaires de Recherche): Large-scale research programs targeting France 2030 priorities, managed by ANR in coordination with research institutions. Active PEPRs include: Cybersecurity, Quantum, AI for Sustainable Industry, Nuclear Materials, Hydrogen, and Electric Vehicles.

CIFRE Grants: Industrial doctoral grants where a PhD student works simultaneously at a company and a research laboratory, with the company paying 50% of the salary and ANR providing the rest. Extremely valuable for deeptech companies wanting to develop PhD-level expertise on specific technology problems.

How to Choose Between Programs

The selection decision tree:

1. What is your TRL?

   • TRL 1–4 → CI Phase 1 or ANR research program
   • TRL 4–6 → CI Phase 2 or i-Nov
   • TRL 6–8 → i-Démo or sector-specific ADEME/Bpifrance AAP
   • TRL 8–9 → First Factory or sector acceleration

2. How large is your project?

   • Under €1M project cost → CI or i-Nov
   • €1M–€10M project cost → i-Nov or i-Démo
   • €10M–€100M project cost → i-Démo, First Factory, or IPCEI
   • Over €100M project cost → IPCEI, sector acceleration, or equity + custom package

3. Is your sector on the current wave’s priority list?

   • Yes → Apply to the relevant sector-specific program or the prioritized generalist wave
   • No → Consider whether your project can be legitimately framed within a priority sector, or wait for a more aligned wave

4. Does your project involve multiple partners?

   • Yes → i-Démo (prefers consortia) or IPCEI (requires European consortium)
   • No → i-Nov or CI (both accessible for solo applicants)

5. Is your company pre-commercial or revenue-generating?

   • Pre-commercial → CI Phase 1 or 2, i-Nov (grant only)
   • Revenue-generating → i-Nov (grant or repayable advance), i-Démo

Frequently Asked Questions

What is the difference between i-Nov and i-Démo?

i-Nov targets early-stage innovation (TRL 4–7) in startups and young SMEs, with grants of €200K–€2M. i-Démo targets large-scale industrial demonstrations (TRL 6–8), with funding of €2M–€30M+, often requiring consortia and producing full-scale demonstrator facilities. The key practical difference: i-Nov is accessible to most innovation-stage startups; i-Démo requires demonstrated technology and a more mature project structure.

How often do France 2030 competitions open?

i-Nov runs 4–6 waves per year. Concours d’Innovation runs 2 waves per year. i-Démo opens 1–2 times per year. Sector-specific ADEME programs open 1–3 times per year depending on the specific program. IPCEI opportunities open rarely (per IPCEI program, every 2–4 years). Monitor bpifrance.fr and ademe.fr continuously or subscribe to their newsletters.

Can I apply for both Bpifrance and ADEME programs for the same project?

No — the same project costs cannot be funded by both operators. However, if your project has distinct phases (e.g., technology development phase funded by Bpifrance + scaling phase funded by ADEME), sequential funding from different operators is permissible. Discuss this explicitly with both operators’ program managers before applying.

What is an AMI and should I respond?

An Appel à Manifestation d’Intérêt (AMI) is an exploratory call where companies express interest in a potential future program. Responses are short (5–15 pages), non-binding, and free. Always respond to relevant AMIs — they shape program design and establish your relationship with the program manager. Missing an AMI for a program you later apply to is a missed opportunity.

Is IPCEI the same as France 2030?

No. IPCEI (Important Projects of Common European Interest) is an EU-level framework allowing enhanced state aid for strategic cross-border projects. France 2030 often funds French participants in IPCEI programs — the two systems are complementary. IPCEI provides the European state aid exception; France 2030 provides the French co-financing within that exception.

Can a single company win multiple France 2030 competitions?

Yes. Many companies have simultaneously active grants from i-Nov (innovation project), i-Démo (demonstration project), and Bpifrance equity investment. The constraint is that the same specific costs cannot be funded by multiple programs — different projects or different cost categories within the same project can be funded separately.

How are France 2030 competitions different from Horizon Europe?

France 2030 competitions are national programs managed by French operators (Bpifrance, ADEME, ANR). Horizon Europe is the EU’s research and innovation funding program. Both can co-fund projects, but through separate processes and funding streams. France 2030 generally moves faster than Horizon Europe (3–6 months vs. 12–18 months to award) and has more flexibility on industrial deployment funding. Horizon Europe offers access to European consortium networks and recognition. Many France 2030 recipients also participate in Horizon Europe programs.

Key Takeaways

• France 2030’s competition landscape maps to the TRL scale — match your program choice to your technology readiness level, not the largest available funding amount.
• Core programs: Concours d’Innovation (pre-seed, TRL 2–5), i-Nov (seed/growth, TRL 4–7), i-Démo (demonstration, TRL 6–8), First Factory (industrialization, TRL 8–9).
• ADEME manages energy-specific programs (hydrogen, decarbonization); ANR manages research programs; Bpifrance manages all others.
• IPCEI is the largest-scale instrument (€50M+ per project) but operates at EU level with a 2–4 year cycle — not appropriate for early-stage companies.
• Always respond to relevant AMIs — they influence program design and cost you little.
• Grant vs. repayable advance distinction matters: grants are better for high-risk projects; repayable advances signal commercial confidence and are repaid upon success.
• The key mistake: applying to a program mismatched to your TRL or project scale, resulting in automatic deselection by technically sophisticated evaluators.

Related Resources

• How to Get France 2030 Funding — complete application guide
• Bpifrance Guide for Entrepreneurs — understanding the primary operator
• France 2030 for Startups — startup-specific program guide
• ADEME Actor Profile — energy and environment programs
• ANR Actor Profile — research funding agency
• All Open Competitions — live program tracker
• France 2030 Regulatory Framework — governance and legal framework